Renub Research’s report covers market dynamics power & energy sectors covering growth driver

Central Nervous System (CNS) drugs market consists of drugs used for the treatment of diseases have an effect on the brain such as epilepsy, Parkinson’s disease, depression and anxiety. Epilepsy is a chronic brain disorder characterized by frequent abductions. Parkinson’s disease is a degenerative CNS disorder associated with symptoms of rigidity and tremor. According to Parkinson’s disease Foundation nearly 7-10 Million people are affected with Parkinson’s disease across the globe. These diseases affect by the neurodegeneration, autoimmune disorders and trauma. Increase in CNS diseases prevalence rates due to aging population, introduction of new class of drugs and increased expenditure on healthcare are the driving force for the growth of CNS Drugs market . In recent years, there is no drug available to cure Alzheimer’s disease, the available medicines only treat the austerity of symptoms and develop the quality of life to some extent. There are lots of companies such as

The global cardiovascular surgery devices market observes an increasing swing as the world stumble under the growing pressure of cardiovascular diseases. Aging Population is expected to be the main contributor to the bright future of the global cardiovascular surgerydevices market. The growing number of cardiac surgeries is also attributable to the poor nutrition, stressful lives, obesity-related issues, and other health problems widespread in the modern world that ultimately lead to cardiovascular diseases.  Oxygenator Market An oxygenator is a medical device that is capable of exchanging oxygen and carbon dioxide in the blood of human patient in surgical procedures that may necessitate the interruption or cessation of blood flow in the body, a critical organ or great blood vessel. An oxygenator is driven by a market desire and market growth in conjunction with the growth of cardiac surgery. Due to the decades of competitive development, oxygenator technology has impro

Proton therapy is a form of particle therapy that has gained wide prominence globally. The first hospital-based proton therapy facility started operations in 1990 at Loma Linda University Medical Center (LLUMC). It remains one of the most comprehensive centers, having treated about 16,884 patients since its inception. Proton therapy carries a price tag as intimidating as its size. Although, still in its infancy, the unprecedented demand of proton therapy for the treatment of cancer has set the platform for the market to move ahead at a rapid pace. The number of centers providing proton therapy in the US is likely to cross 22 by 2017. The adoption of proton therapy into regular clinical practice may have a significant economic impact. While proton therapy has been used clinically for more than 20 years, the high cost of the technology has made limited access to the treatment. However the scenario is changing, as manufacturers build more compact systems and cost-effective mode

Pain management is one of the fastest growing medical disciplines that reduce chronic pain. Chronic pain afflicts a large population in the United States. The pain management therapeutics market in United States has huge potential for growth as high population is affected by medically significant pain. The pain management market is fuelled by the segment like arthritis pain, cancer pain, fibromyalgia, back pain, neuropathic pain, migraine pain, and post-operative pain relief markets. Pain is a widespread problem across the United States. The pain management market is growing fuelled by cancer pain, back pain, and post-operative pain relief markets. Currently, the management of pain is not efficient due to low diagnosis and prescription rates. In most of the cases, such as cancer pain, 50% of the people taking medicines are not satisfied with the results. This is mainly due to the absence of a perfect pain management solution. Pain management can be highly effective only when the und